Table 1 Characteristics of the study population (n = 69)
Age (years) | 64.4 ± 17.9; 69 (28 to 89) |
Sex (males, %) | 43 (62.3%) |
APACHE II score | 22.1 ± 6.2; 21 (14 to 35) |
SOFA score | 8.4 ± 3.2; 8 (4 to 16) |
Lung compliance (ml/cmH2O) | 29.4 ± 7.2; 30 (17 to 40) |
PaO2/FiO2 | 139, 1 ± 47.1; 140 (72 to 223) |
PEEP | 8.1 ± 2.9; 8 (5 to 15) |
Lung Injury Score | 2.5 ± 0.6; 2.5 (1.75 to 3.50) |
Blood lactate (mmol/l) | 1.7 ± 1.7; 1.3 (0.5 to 5.2) |
Septic status | 39 (56.5%) |
Serum ACE (U/l) | 16.5 ± 10.8; 13.6 (4.8 to 39.8) |
BALF (U/l) | 2.3 ± 1.4; 2.0 (0.3 to 4.7) |
ACE I/D polymorphism: | Â |
   D/D | 27 (39.1%) |
   I/D | 28 (40.6%) |
   I/I | 14 (20.3%) |
28-day mortality | 34/69 (49.3%) |
90-day mortality | 43/69 (62.3%) |
Ventilator-free days | 5.1 ± 7.8; (0 to 23) |
Days w/o cardiovascular failure | 14.0 ± 10.2; 16 (0 to 27) |
Days w/o renal failure | 15.4 ± 10.6; 16 (0 to 28) |